Prevention of typhoid fever: Role of technology transfer for development of better vaccines

• Reviewing the regulatory capacity of India’s vaccine manufacturers
• Understanding India’s patent law and ensuring product infringement and patent claims
• Avoiding product timeline delay and missed development opportunities

Providing better IP protection in India

• Reviewing the regulatory capacity of India’s vaccine manufacturers
• Understanding India’s patent law and ensuring product infringement and patent claims
• Avoiding product timeline delay and missed development opportunities

Mahalaxmi Andheria, Vice President- Intellectual Property Cell, Panacea Biotec

Regulatory requirements and quality compliance in India

• Reviewing India’s current manufacturing strategies and its loopholes
• Mapping the regulatory timeline of vaccines in India
• Gaining support from the industry for stronger infrastructures to prioritize quality

IVAC’s pandemic and seasonal influenza vaccine development

• Exploring the manufacturing capability of Vietnam
• Optimizing cost-effective processes for large-scale vaccine production in developing markets
• Developing flexible manufacturing facilities to tailor to the different countries and pandemic outbreaks

Table A: Preparing for WHO prequalification

Table B: Vaccine thermostability: Tools to ensure safe & effective vaccine access

Mr Jeff Baxter, Chief Executive Officer, VBI Vaccines